Fred B. Craves, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 26,765 shares at $329.86 ($8.8M) on 2025-03-13, disclosed to the SEC on 2025-03-14.
Open-market sale of $8.8M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $330.54 | 1,587 | $525K | 6.0% |
| 2 | $330.54 | 1,587 | $525K | 6.0% |
| 3 | $331.36 | 2,759 | $914K | 10.4% |
| 4 | $331.36 | 2,759 | $914K | 10.4% |
| 5 | $332.38 | 2,382 | $792K | 9.0% |
| 6 | $332.38 | 2,382 |
| $792K |
| 9.0% |
| 7 | $333.66 | 800 | $267K | 3.0% |
| 8 | $334.97 | 200 | $67K | 0.8% |
| 9 | $322.45 | 1,951 | $629K | 7.2% |
| 10 | $322.45 | 1,951 | $629K | 7.2% |
| 11 | $323.47 | 1,649 | $533K | 6.1% |
| 12 | $323.47 | 1,649 | $533K | 6.1% |
| 13 | $324.69 | 900 | $292K | 3.3% |
| 14 | $325.63 | 800 | $261K | 3.0% |
| 15 | $327.63 | 1,000 | $328K | 3.7% |
| 16 | $328.68 | 400 | $131K | 1.5% |
| 17 | $329.86 | 967 | $319K | 3.6% |
| 18 | $329.86 | 967 | $319K | 3.6% |
| 19 | $330.23 | 75 | $25K | 0.3% |
| Total | $328.58 avg | 26,765 | $8.8M | 100% |
| Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |
| MDGL | SELL | 2019-12-13 | $253.1M | — | Filing → |